Prescription drug · ANDA
Edaravone NDC 66794-259
Edaravone 30 mg/100mL · Injection, Solution · Intravenous · Piramal Critical Care Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66794-259-64 | 66794025964 | 2 POUCH in 1 CARTON (66794-259-64) / 1 BAG in 1 POUCH / 100 mL in 1 BAGMarketed from Jul 8, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Edaravone
- Generic name (nonproprietary)
- edaravone
- Active ingredients
- Edaravone — 30 mg/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Piramal Critical Care Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216199
- Marketing start
- Listing expires
- Identifiers
- Product ID 66794-259_40905b35-f5ad-1c99-e063-6294a90a22d4SPL ID 40905b35-f5ad-1c99-e063-6294a90a22d4SPL set ID 19862ae9-d6e1-70e6-e063-6394a90ae749RxCUI 1924316UNII S798V6YJRP
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N466794025964followed by a unit qualifier and the quantityPackage 66794-0259-64. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS). Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 216199
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.